Literature DB >> 11288804

Primary aldosteronism: revival of a syndrome.

M Stowasser.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11288804     DOI： 10.1097/00004872-200103000-00002

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  8 in total

Review 1.  Is the vascular endothelium under the control of aldosterone? Facts and hypothesis.

Authors:  Hans Oberleithner
Journal:  Pflugers Arch       Date:  2007-02-07       Impact factor: 3.657

Review 2.  Miscellaneous endocrine causes of hypertension.

Authors:  Richard J Auchus
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

Review 3.  [Modern pharmacological aspects of hyperaldosteronism therapy].

Authors:  M Quinkler; M Reincke
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

Review 4.  Aldosterone: a risk factor for vascular disease.

Authors:  Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

5.  Adrenal incidentalomas: experience in a developing country.

Authors:  P R K Bhargav; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

6.  Plasma sodium stiffens vascular endothelium and reduces nitric oxide release.

Authors:  Hans Oberleithner; Christoph Riethmüller; Hermann Schillers; Graham A MacGregor; Hugh E de Wardener; Martin Hausberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

7.  Current concepts in the management of adrenal incidentalomas.

Authors:  Prashanth Kanagarajah; Rajinikanth Ayyathurai; Murugesan Manoharan; Govindarajan Narayanan; Bruce R Kava
Journal:  Urol Ann       Date:  2012-09

Review 8.  Aldosteronoma.

Authors:  Laurent Brunaud; Quan-Yang Duh
Journal:  Curr Treat Options Oncol       Date:  2002-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.